These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11400754)

  • 1. Screening for hyperhomocysteinemia in young adults with premature coronary artery disease.
    Cerone R; Minniti G; Piana A; Armani U; Susco G; Bertolini S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():148. PubMed ID: 11400754
    [No Abstract]   [Full Text] [Related]  

  • 2. Helicobacter pylori infection does not affect the serum level of homocysteine.
    Yoshino N; Adachi K; Takashima T; Miyaoka Y; Yuki T; Ishihara S; Kinoshita Y
    Am J Gastroenterol; 2002 Nov; 97(11):2927-8. PubMed ID: 12425577
    [No Abstract]   [Full Text] [Related]  

  • 3. [Homocysteine, lipoprotein (a): risk factors for coronary heart disease].
    Laraqui A; Bennouar N; Meggouh F; Allami A; El Kadiri N; Benkouka F; Azeddoug H; El Haitem N; Benomar A; Fellat S; Benomar M
    Ann Biol Clin (Paris); 2002; 60(5):549-57. PubMed ID: 12368140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke.
    Parnetti L; Caso V; Santucci A; Corea F; Lanari A; Floridi A; Conte C; Bottiglieri T
    Neurol Sci; 2004 Apr; 25(1):13-7. PubMed ID: 15060810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia and the risk of restenosis after coronary artery stenting: fact or fiction?
    Tabrizchi R
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):935-9. PubMed ID: 15500438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperhomocysteinemia. A new coronary risk factor].
    Zacarías-Castillo R; Hernández-Rebollar AE; Zajarias-Rabchinskey A; González-Bárcena D
    Gac Med Mex; 2001; 137(4):335-45. PubMed ID: 11519357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteinemia as an independent risk factor in the Chinese population at a high risk of coronary artery disease.
    Ni M; Zhang XH; Jiang SL; Zhang Y
    Am J Cardiol; 2007 Aug; 100(3):455-8. PubMed ID: 17659928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Homocysteinemia and coronary artery disease: a case-control study in a Tunisian population].
    Souissi M; Feki M; Mourali S; Enneifer M; Omar S; Sanhaji H; Mechmeche R; Mebazaa A; Kaabachi N
    Arch Mal Coeur Vaiss; 2006 Sep; 99(9):781-5. PubMed ID: 17067095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of hyperhomocysteinemia in cervical artery dissection causing stroke: a case-control study.
    Benninger DH; Herrmann FR; Georgiadis D; Kretschmer R; Sarikaya H; Schiller A; Baumgartner RW
    Cerebrovasc Dis; 2009; 27(3):241-6. PubMed ID: 19176957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.
    Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G
    Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing coronary artery disease by decreasing homocysteine levels.
    Coffey M; Crowder GK; Cheek DJ
    Crit Care Nurse; 2003 Feb; 23(1):25-30. PubMed ID: 12640957
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary artery disease and homocysteine: a case study.
    Shinnick MA; Holmes LI
    Am J Crit Care; 1999 May; 8(3):193-6. PubMed ID: 10228661
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperhomocysteinemia and the compound heterozygous state for methylene tetrahydrofolate reductase are independent risk factors for deep vein thrombosis among South Indians.
    Naushad S; Jamal NJ; Angalena R; Prasad CK; Devi AR
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):113-7. PubMed ID: 17287626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family history, plasma homocysteine, and age at onset of symptoms of myocardial ischemia in patients with different methylenetetrahydrofolate reductase genotypes.
    Mager A; Koren-Morag N; Shohat M; Harell D; Battler A
    Am J Cardiol; 2005 Jun; 95(12):1420-4. PubMed ID: 15950563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia, coronary heart disease, and diabetes mellitus as predicted by various definitions for metabolic syndrome in a hypertensive Saudi population.
    Al-Daghri NM
    Saudi Med J; 2007 Mar; 28(3):339-46. PubMed ID: 17334456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism.
    Gonzalez-Porras JR; Martin-Herrero F; Garcia-Sanz R; Lopez ML; Balanzategui A; Mateos MV; Pavon P; Gonzalez M; Alberca I; San Miguel JF
    Thromb Res; 2007; 119(6):691-8. PubMed ID: 17005242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of total homocysteine in plasma: comparison of the Abbott IMx immunoassay with high performance liquid chromatography.
    Zighetti ML; Chantarangkul V; Tripodi A; Mannucci PM; Cattaneo M
    Haematologica; 2002 Jan; 87(1):89-94. PubMed ID: 11801469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperhomocysteinemia and advancement of atherosclerosis in patients with chronic renal failure on maintenance hemodialysis].
    Sydor A; Drozdz M; Kraśniak A; Miłkowski A; Chmiel G; Małczak J; Zabawa-Hołyś S; Moskal K; Podwysocki A; Szmigielski M; Czarnecka D; Gozdecka H; Kowalczyk-Michałek M; Szczeklik A; Wiecek A; Sułowicz W
    Przegl Lek; 2002; 59(12):962-7. PubMed ID: 12731367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.